Tapewire

Nasdaq · USD

KTTA

Pasithea Therapeutics Corp.

Export transactions ↓
Tapewire entity
7685
SEC CIK
0001841330
Parsed reports
80

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202530
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202610
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 17, 2026 Filed Jun 22, 2026 14:30 UTC PurchaseCommon Stock 100,000 $0.53 $53,000.00
Disclosure

SEC source: 0001104659-26-076184 · tm2618440-1_4seq1.xml · nonDerivative · entry 1

Coastlands Capital LP · CIK 0002068530 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Coastlands Capital LP

Disclosed balance after: 3,835,035

F1 · ownership.nature: Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.

Read SEC document
May 01, 2026 Filed May 5, 2026 20:41 UTC
Leahy EmerDirector
GrantStock Option (right to buy) · Derivative 152,783 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001213900-26-052257 · ownership.xml · derivative · entry 1

Leahy Emer · CIK 0001875180 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,783

Underlying: Common Stock · 152,783 shares

Expires 2036-04-30

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

Read SEC document
May 01, 2026 Filed May 5, 2026 20:42 UTC GrantStock Option (right to buy) · Derivative 152,783 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001213900-26-052261 · ownership.xml · derivative · entry 1

STEINMAN LAWRENCE · CIK 0001132679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,783

Underlying: Common Stock · 152,783 shares

Expires 2036-04-30

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

Read SEC document
May 01, 2026 Filed May 5, 2026 20:41 UTC GrantStock Option (right to buy) · Derivative 152,783 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001213900-26-052260 · ownership.xml · derivative · entry 1

Dumesnil Simon · CIK 0001875691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,783

Underlying: Common Stock · 152,783 shares

Expires 2036-04-30

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

Read SEC document
May 01, 2026 Filed May 5, 2026 20:42 UTC
Marques TiagoDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 1,756,069 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001213900-26-052262 · ownership.xml · derivative · entry 1

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,756,069

Underlying: Common Stock · 1,756,069 shares

Expires 2036-04-30

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan).

Read SEC document
May 01, 2026 Filed May 5, 2026 20:40 UTC GrantStock Option (right to buy) · Derivative 152,783 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001213900-26-052256 · ownership.xml · derivative · entry 1

Novak Alfred J · CIK 0001388862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,783

Underlying: Common Stock · 152,783 shares

Expires 2036-04-30

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

Read SEC document
May 01, 2026 Filed May 5, 2026 20:41 UTC
Schneiderman Daniel HChief Financial Officer
GrantStock Option (right to buy) · Derivative 1,129,323 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001213900-26-052259 · ownership.xml · derivative · entry 1

Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,129,323

Underlying: Common Stock · 1,129,323 shares

Expires 2036-04-30

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan).

Read SEC document
May 01, 2026 Filed May 5, 2026 20:41 UTC
Krishnan KartikChief Medical Officer
GrantStock Option (right to buy) · Derivative 1,129,323 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001213900-26-052258 · ownership.xml · derivative · entry 1

Krishnan Kartik · CIK 0002131061 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,129,323

Underlying: Common Stock · 1,129,323 shares

Expires 2036-04-30

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan).

Read SEC document
November 28, 2025 Filed Dec 1, 2025 13:51 UTC
Leahy EmerDirector
GrantCommon Stock 33,333 $0.75 $24,999.75
Disclosure

SEC source: 0001213900-25-116296 · ownership.xml · nonDerivative · entry 1

Leahy Emer · CIK 0001875180 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,333

Read SEC document
November 28, 2025 Filed Dec 1, 2025 14:07 UTC PurchaseCommon Stock 133,333 $0.75 $99,999.75
Disclosure

SEC source: 0001213900-25-116309 · ownership.xml · nonDerivative · entry 1

STEINMAN LAWRENCE · CIK 0001132679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,691

Read SEC document
November 28, 2025 Filed Dec 1, 2025 13:54 UTC PurchaseCommon Stock 33,333 $0.75 $24,999.75
Disclosure

SEC source: 0001213900-25-116299 · ownership.xml · nonDerivative · entry 1

Dumesnil Simon · CIK 0001875691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,833

Read SEC document
November 28, 2025 Filed Dec 1, 2025 13:56 UTC
Marques TiagoDirector · Chief Executive Officer
PurchaseCommon Stock 33,333 $0.75 $24,999.75
Disclosure

SEC source: 0001213900-25-116301 · ownership.xml · nonDerivative · entry 1

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,334

Read SEC document
November 28, 2025 Filed Dec 1, 2025 14:04 UTC
Schneiderman Daniel HChief Financial Officer
GrantCommon Stock 26,667 $0.75 $20,000.25
Disclosure

SEC source: 0001213900-25-116306 · ownership.xml · nonDerivative · entry 1

Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,667

Read SEC document
October 24, 2025 Filed Oct 27, 2025 21:26 UTC
Leahy EmerDirector
GrantStock Option (right to buy) · Derivative 42,913 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001213900-25-102676 · ownership.xml · derivative · entry 1

Leahy Emer · CIK 0001875180 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,913

Underlying: Common Stock · 42,913 shares

Expires 2035-10-23

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

Read SEC document
October 24, 2025 Filed Oct 27, 2025 21:27 UTC GrantStock Option (right to buy) · Derivative 242,913 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001213900-25-102682 · ownership.xml · derivative · entry 1

STEINMAN LAWRENCE · CIK 0001132679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,913

Underlying: Common Stock · 242,913 shares

Expires 2035-10-23

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

Read SEC document
October 24, 2025 Filed Oct 27, 2025 21:25 UTC GrantStock Option (right to buy) · Derivative 42,913 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001213900-25-102674 · ownership.xml · derivative · entry 1

Dumesnil Simon · CIK 0001875691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,913

Underlying: Common Stock · 42,913 shares

Expires 2035-10-23

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

Read SEC document
October 24, 2025 Filed Oct 27, 2025 21:26 UTC
Marques TiagoDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 493,341 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001213900-25-102677 · ownership.xml · derivative · entry 1

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 493,341

Underlying: Common Stock · 493,341 shares

Expires 2035-10-23

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan).

Read SEC document
October 24, 2025 Filed Oct 27, 2025 21:26 UTC GrantStock Option (right to buy) · Derivative 42,913 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001213900-25-102680 · ownership.xml · derivative · entry 1

Novak Alfred J · CIK 0001388862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,913

Underlying: Common Stock · 42,913 shares

Expires 2035-10-23

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

Read SEC document
October 24, 2025 Filed Oct 27, 2025 21:27 UTC
Schneiderman Daniel HChief Financial Officer
GrantStock Option (right to buy) · Derivative 317,266 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001213900-25-102681 · ownership.xml · derivative · entry 1

Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,266

Underlying: Common Stock · 317,266 shares

Expires 2035-10-23

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan).

Read SEC document
May 12, 2025 Filed May 15, 2025 01:55 UTC
Marques TiagoDirector · Chief Executive Officer
SaleCommon Stock 960 $0.83 $792.00
Disclosure

SEC source: 0001213900-25-043621 · ownership.xml · nonDerivative · entry 1

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,001

F1 · shares: The Reporting Person previously held 960 shares of Common Stock of the Issuer in a foreign brokerage account that was recently wound down. As a result, the foreign broker automatically liquidated the Reportion Person's account on May 12, 2025 by selling the 960 shares of Common Stock of the Issuer on a non-discretionary basis.

Read SEC document
June 13, 2024 Filed Jun 14, 2024 21:25 UTC GrantCommon Stock 2,750 $5.62 $15,455.00
Disclosure

SEC source: 0001213900-24-053005 · ownership.xml · nonDerivative · entry 2

Novak Alfred J · CIK 0001388862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,500

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.55 to $5.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 21:25 UTC GrantCommon Stock 750 $5.61 $4,207.50
Disclosure

SEC source: 0001213900-24-053005 · ownership.xml · nonDerivative · entry 1

Novak Alfred J · CIK 0001388862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.60 to $5.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 02:46 UTC
Leahy EmerDirector
GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $8.34 $0.00
Disclosure

SEC source: 0001213900-24-019218 · ownership.xml · derivative · entry 1

Leahy Emer · CIK 0001875180 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 02:47 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $8.34 $0.00
Disclosure

SEC source: 0001213900-24-019222 · ownership.xml · derivative · entry 1

STEINMAN LAWRENCE · CIK 0001132679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 02:45 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $8.34 $0.00
Disclosure

SEC source: 0001213900-24-019217 · ownership.xml · derivative · entry 1

Dumesnil Simon · CIK 0001875691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 02:46 UTC
Marques TiagoDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 11,669 $0.00 Strike: $8.34 $0.00
Disclosure

SEC source: 0001213900-24-019219 · ownership.xml · derivative · entry 2

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,669

Underlying: Common Stock · 11,669 shares

Expires 2034-02-28

F2 · derivative.exercise_date: The option award was made in accordance with the terms of the 2023 Plan. The option award fully vested upon issuance and became exercisable on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 02:46 UTC
Marques TiagoDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $8.34 $0.00
Disclosure

SEC source: 0001213900-24-019219 · ownership.xml · derivative · entry 1

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan (the "2023 Plan"). The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the option award will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains a director or otherwise in continuous service to the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 02:46 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $8.34 $0.00
Disclosure

SEC source: 0001213900-24-019220 · ownership.xml · derivative · entry 1

Novak Alfred J · CIK 0001388862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 02:46 UTC
Schneiderman Daniel HChief Financial Officer
GrantStock Option (right to buy) · Derivative 5,927 $0.00 Strike: $8.34 $0.00
Disclosure

SEC source: 0001213900-24-019221 · ownership.xml · derivative · entry 2

Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,927

Underlying: Common Stock · 5,927 shares

Expires 2034-02-28

F2 · derivative.exercise_date: The option award was made in accordance with the terms of the 2023 Plan. The option award fully vested upon issuance and became exercisable on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 02:46 UTC
Schneiderman Daniel HChief Financial Officer
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $8.34 $0.00
Disclosure

SEC source: 0001213900-24-019221 · ownership.xml · derivative · entry 1

Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan (the "2023 Plan"). The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the option award will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 02:45 UTC
Currie Graeme MartinChief Development Officer
GrantStock Option (right to buy) · Derivative 5,938 $0.00 Strike: $8.34 $0.00
Disclosure

SEC source: 0001213900-24-019216 · ownership.xml · derivative · entry 1

Currie Graeme Martin · CIK 0001965006 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,938

Underlying: Common Stock · 5,938 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The Option fully vested upon issuance and became exercisable on March 1, 2024.

Read SEC document
March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment
Leahy EmerDirector
GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001213900-24-030962 · ownership.xml · derivative · entry 1

Leahy Emer · CIK 0001875180 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-02-28

F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share.

F2 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001213900-24-030957 · ownership.xml · derivative · entry 1

STEINMAN LAWRENCE · CIK 0001132679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-02-28

F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share.

F2 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001213900-24-030958 · ownership.xml · derivative · entry 1

Dumesnil Simon · CIK 0001875691 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-02-28

F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share.

F2 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment
Marques TiagoDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 11,669 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001213900-24-030963 · ownership.xml · derivative · entry 2

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,669

Underlying: Common Stock · 11,669 shares

Expires 2034-02-28

F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share.

F3 · derivative.exercise_date: The option award was made in accordance with the terms of the 2023 Plan. The option award fully vested upon issuance and became exercisable on March 1, 2024.

Read SEC document
March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment
Marques TiagoDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001213900-24-030963 · ownership.xml · derivative · entry 1

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-02-28

F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share.

F2 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan (the "2023 Plan"). The shares of Common Stock underlying the option award will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains a director or otherwise in continuous service to the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001213900-24-030960 · ownership.xml · derivative · entry 1

Novak Alfred J · CIK 0001388862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-02-28

F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share.

F2 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment
Schneiderman Daniel HChief Financial Officer
GrantStock Option (right to buy) · Derivative 5,927 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001213900-24-030961 · ownership.xml · derivative · entry 2

Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,927

Underlying: Common Stock · 5,927 shares

Expires 2034-02-28

F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share.

F3 · derivative.exercise_date: The option award was made in accordance with the terms of the 2023 Plan. The option award fully vested upon issuance and became exercisable on March 1, 2024.

Read SEC document
March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment
Schneiderman Daniel HChief Financial Officer
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001213900-24-030961 · ownership.xml · derivative · entry 1

Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-02-28

F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share.

F2 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan (the "2023 Plan"). The shares of Common Stock underlying the option award will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment
Currie Graeme MartinChief Development Officer
GrantStock Option (right to buy) · Derivative 5,938 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001213900-24-030959 · ownership.xml · derivative · entry 1

Currie Graeme Martin · CIK 0001965006 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,938

Underlying: Common Stock · 5,938 shares

Expires 2034-02-28

F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share.

F2 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The Option fully vested upon issuance and became exercisable on March 1, 2024.

Read SEC document
June 02, 2023 Filed Jun 7, 2023 01:00 UTC PurchaseCommon Stock 30,000 $0.43 $12,930.00
Disclosure

SEC source: 0001493152-23-020333 · ownership.xml · nonDerivative · entry 1

STEINMAN LAWRENCE · CIK 0001132679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,327,174

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.38 to $0.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Read SEC document
November 28, 2022 Filed Nov 28, 2022 21:00 UTC GrantCommon Stock 5,000 $0.98 $4,900.00
Disclosure

SEC source: 0001213900-22-075491 · ownership.xml · nonDerivative · entry 1

STEINMAN LAWRENCE · CIK 0001132679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,287,174

Read SEC document
November 25, 2022 Filed Nov 28, 2022 21:00 UTC
Marques TiagoDirector · Chief Executive Officer
GrantCommon Stock 2,000 $1.03 $2,060.00
Disclosure

SEC source: 0001213900-22-075490 · ownership.xml · nonDerivative · entry 4

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 819,206

Read SEC document
November 23, 2022 Filed Nov 28, 2022 21:00 UTC
Marques TiagoDirector · Chief Executive Officer
GrantCommon Stock 1,206 $1.02 $1,230.12
Disclosure

SEC source: 0001213900-22-075490 · ownership.xml · nonDerivative · entry 3

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 817,206

Read SEC document
November 23, 2022 Filed Nov 28, 2022 21:00 UTC
Marques TiagoDirector · Chief Executive Officer
GrantCommon Stock 1,000 $1.03 $1,030.00
Disclosure

SEC source: 0001213900-22-075490 · ownership.xml · nonDerivative · entry 2

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 816,000

Read SEC document
November 23, 2022 Filed Nov 28, 2022 21:00 UTC
Marques TiagoDirector · Chief Executive Officer
GrantCommon Stock 5,000 $1.00 $5,000.00
Disclosure

SEC source: 0001213900-22-075490 · ownership.xml · nonDerivative · entry 1

Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 815,000

Read SEC document
November 22, 2022 Filed Nov 22, 2022 21:10 UTC GrantCommon Stock 5,000 $0.99 $4,950.00
Disclosure

SEC source: 0001213900-22-074585 · ownership.xml · nonDerivative · entry 1

STEINMAN LAWRENCE · CIK 0001132679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,282,174

Read SEC document
November 17, 2022 Filed Nov 17, 2022 21:34 UTC GrantCommon Stock 40,000 $1.06 $42,400.00
Disclosure

SEC source: 0001213900-22-073502 · ownership.xml · nonDerivative · entry 2

Dumesnil Simon · CIK 0001875691 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Read SEC document
November 15, 2022 Filed Nov 17, 2022 21:34 UTC GrantCommon Stock 10,000 $1.07 $10,700.00
Disclosure

SEC source: 0001213900-22-073502 · ownership.xml · nonDerivative · entry 1

Dumesnil Simon · CIK 0001875691 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
October 26, 2022 Filed Oct 26, 2022 21:35 UTC GrantCommon Stock 5,000 $1.10 $5,500.00
Disclosure

SEC source: 0001213900-22-066554 · ownership.xml · nonDerivative · entry 1

STEINMAN LAWRENCE · CIK 0001132679 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,277,174

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.